Cloud Range Wins Gold in 2026 Cybersecurity Excellence Awards for Cyber Readiness and Validation Cloud Range, the industry-leading cyber readiness and simulation platform, has been named a Gold Award recipient in the Cyber Readiness and Validation category of the 2026…
CatalYm Doses First Patient in Phase 2b Trial Evaluating Visugromab in Combination with Chemoimmunotherapy as Second-Line Treatment in Unresectable/Metastatic Hepatocellular Carcinoma CatalYm announced that the first patient has been dosed in the GDFATHER-HCC-01 trial The trial evaluates the company’s lead anti-GDF-15…
Pulse Biosciences Enrolls First Patients in NANOPULSE-AF IDE Pivotal Clinical Study Evaluating nPulse™ Cardiac Catheter System for Atrial Fibrillation Pulse Biosciences, Inc. developer of nPulse™ technology using proprietary nanosecond pulsed field ablation (nsPFA™) energy, today announced enrollment of the first…
AIRNA Announces First Patient Dosed in Phase 1 Trial of AIR-001, Potential Best-in-Class RNA-Editing Therapy for Alpha-1 Antitrypsin Deficiency (AATD) AIRNA, a biotech company pioneering RNA-editing therapeutics to transform the lives of patients with rare and common conditions, announced the…
Ducon Announces Advanced Solutions to Mitigate Air Pollution from Missile Interceptions Ducon Technologies a global leader in high-efficiency air pollution control and infrastructure related technologies, announced solutions for the escalating environmental and public health crisis caused by high-altitude missile interceptions…
Aspect Biosystems Announces $280 Million Partnership with Government of Canada to Advance Development of Bioengineered Cellular Medicines Aspect Biosystems, a biotechnology company pioneering a novel category of regenerative medicine, today announced that it has received a $79 million investment from…
Swaney Group Capital and LongueVue Capital Invest in Apex Dental Laboratory Group Swaney Group Capital a Tampa-based private equity firm, in partnership with LongueVue Capital a New Orleans-based private equity firm, announced a strategic investment in Apex Dental Laboratory Group (“Apex”…
CTIS, Inc. Launches Trial SafetyXchange to Help Pharma Companies Meet Critical FDA E2B(R3) Compliance Deadline CTIS, Inc., with more than 30 years of experience in Health IT and clinical research informatics expertise for government and industry clients, today announced the…
Harmony Biosciences Strengthens Executive Team With New Appointment and Announces Additions to Its Board Harmony Biosciences Holdings, Inc. announced the appointment of Peter Anastasiou as Chief Operating Officer and updates to its Board of Directors, including the appointment of Troy…
Clarametyx Biosciences Strengthens Executive Leadership to Accelerate Clinical Development Efforts Clarametyx Biosciences, Inc. a clinical-stage biotechnology company developing immune-enabling therapies and vaccines to address biofilm-driven chronic respiratory disease, today announced two senior leadership positions within its executive team to support…
Coya Therapeutics Announces Planned Board Transition and Appointment of Mark H. Pavao as Independent Director Coya Therapeutics, Inc. a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with neurodegenerative disorders, today announced that founder Howard Berman,…
CorVista Health Demonstrates High-Sensitivity for Noninvasive Detection of CAD including INOCA (Ischemia with No Obstructed Coronary Arteries) at ACC.26 CorVista Health, a leader in noninvasive cardiovascular diagnostics, announced new data evaluating a physiologic signal–based machine-learning model for detecting cardiac ischemia.…